Table 2 Crosstabulations of DMARD and Prednisolone treatment in the Never and Ever erosion groups over 8 years
From: Erosion-free rheumatoid arthritis: clinical and conceptional implications—a BARFOT study
Never erosions | Ever erosions | Diff | |||
|---|---|---|---|---|---|
n = 144 | n = 464 | ||||
N (%) | SR* | N (%) | SR* | p- value | |
Treatment start | |||||
No DMARD No Pred | 22 (15) | ≥ + 2 | 33 (7) | 0.003 | |
cDMARDs | 104 (72) | 394 (85) | |||
bDMARDs | 6 (4) | 8 (2) | |||
Pred only | 12 (8) | 29 (6) | |||
Treatment 0.5 yr | |||||
No DMARD No Pred | 21 (16) | ≥ + 2 | 37 (9) | 0.003 | |
cDMARDs | 93 (70) | 365 (84) | |||
bDMARDs | 8 (6) | ≥ + 2 | 9 (2) | ||
Pred only | 10 (8) | 22 (5) | |||
Treatment 1 yr | |||||
No DMARD No Pred | 30 (21) | ≥ + 2 | 40 (9) | 0.001 | |
cDMARDs | 96 (68) | 379 (84) | |||
bDMARDs | 9 (6) | 20 (4) | |||
Pred only | 7 (5) | 11 (2) | |||
Treatment 2 yrs | |||||
No DMARD No Pred | 35 (26) | ≥ + 2 | 45 (10) | ≤ − 2 | 0.001 |
cDMARDs | 80 (58) | ≤ − 2 | 349 (78) | ||
bDMARDs | 10 (7) | 36 (8) | |||
Pred only | 12 (9) | ≥ + 2 | 16 (4) | ||
Treatment 5 yrs | |||||
No DMARD No Pred | 54 (39) | ≥ + 2 | 68 (15) | ≤ − 2 | 0.001 |
cDMARDs | 61 (44) | ≤ − 2 | 303 (68) | ||
bDMARDs | 14 (10) | 61 (14) | |||
Pred only | 9 (7) | 14 (3) | |||
Treatment 8 yrs | |||||
No DMARD No Pred | 50 (35) | ≥ +2 | 81 (18) | 0.001 | |
cDMARDs | 74 (52) | 299 (65) | |||
bDMARDs | 7 (5) | ≤ − 2 | 58 (13) | ||
Pred only | 12 (8) | 19 (4) | |||